The matter relates to supply of polysaccharide Quadrivalent Meningococcal Meningitis (QMMV) vaccines and the complaint was filed by Bio-Med Pvt Ltd, which also makes this drug. The complaint was also filed against the Health and Family Welfare Ministry.

Every year, the government invites tenders for purchase of meningitis vaccine that is required to be administered upon Haj pilgrims. Apart from imposing penalties, the Commission has directed GlaxoSmithKline and Sanofi to 'cease and desist' from anti-competitive practices.

A fine of Rs 60.45 crore has been slapped on GlaxoSmithKline and Rs 3.04 crore on Sanofi, CCI said. The penalties amount to three percent of their three-year average turnover. In this case, turnovers of the two companies for the financial years 2008, 2009 and 2010 have been taken into account.

Latest News  from Business News Desk